GlassScriptPhysician profile
Nicole Eileen Micklus
NPI 1780439893
$1,839.57
in general payments reported to CMS, 2019-2025
18 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $29.58 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.59 |
| Education | $236.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $252.32 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $234.32 | 2025 | |
| Lilly USA, LLC | $157.82 | 2024-2025 | Ebglyss, Mounjaro, Taltz |
| Arcutis Biotherapeutics, INC. | $157.52 | 2025 | Zoryve |
| Galderma Laboratories, L.P. | $149.71 | 2025 | Nemluvio |
| Ucb, INC. | $124.55 | 2025 | Bimzelx |
| Novo Nordisk INC | $120.79 | 2025 | Ozempic |
| Regeneron Healthcare Solutions, INC. | $113.23 | 2025 | Dupixent |
| Incyte Corporation | $98.50 | 2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $84.99 | 2025 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Genzyme Corporation | $71.23 | 2025 | |
| Amgen INC. | $65.66 | 2025 | Otezla |
| Almirall LLC | $40.57 | 2025 | Klisyri |
| Abbvie INC. | $35.03 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $21.71 | 2025 | Nucala |
| E.R. Squibb & Sons, L.L.C. | $16.61 | 2025 | Sotyktu |
| Janssen Pharmaceuticals, INC | $15.02 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Micklus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.